Valuation: Dr. Reddy's Laboratories Limited

Market Cap 1,019B 10.58B 9.25B 8.55B 7.85B 14.85B 15.11B 102B 40.05B 498B 39.72B 38.85B 1,718B P/E 2027 *
24.2x
P/E 2028 * 19.4x
Enterprise Value 986B 10.24B 8.95B 8.28B 7.59B 14.37B 14.62B 98.7B 38.77B 482B 38.45B 37.6B 1,663B EV / Sales 2027 *
2.77x
EV / Sales 2028 * 2.44x
Free-Float
70.07%
Yield 2027 *
0.63%
Yield 2028 * 0.69%

Last Transcript: Dr. Reddy's Laboratories Limited

1 week-3.55%
Current month-9.78%
1 month-4.11%
3 months+0.25%
6 months+4.16%
Current year-3.70%
1 week 1,204
Extreme 1204
1,251.8
1 month 1,204
Extreme 1204
1,414.9
3 years 1,018.6
Extreme 1018.6
1,421.49
5 years 730.8
Extreme 730.8
1,421.49
10 years 374.59
Extreme 374.59
1,421.49
Manager TitleAgeSince
Chief Executive Officer 59 2019-06-30
Director of Finance/CFO - 2024-07-31
Chief Operating Officer - -
Director TitleAgeSince
Chairman 58 2014-05-12
Chairman 65 2013-04-01
Director/Board Member 65 2018-10-24
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-3.55%-2.78%+20.23% 10.58B
+1.08%-3.93%+48.03%+160.13% 1,043B
+1.19%-3.52%+51.70%+56.36% 602B
+4.21%+1.79%+33.48%+87.04% 449B
+0.27%-1.07%+29.57%+24.16% 327B
+0.70%0.00%+33.15%+46.35% 279B
-0.36%-1.81%+22.21%+23.55% 264B
+3.70%+2.19%+24.27%+63.38% 201B
+3.49%+1.08%+24.08%+76.58% 169B
+1.29%+3.67%+2.15%-30.78% 143B
Average +1.43%-0.68%+26.59%+52.70% 386.34B
Weighted average by Cap. +1.57%-1.82%+37.34%+82.72%

Financials

2027 *2028 *
Net sales 356B 3.7B 3.23B 2.99B 2.74B 5.19B 5.28B 35.63B 14B 174B 13.88B 13.57B 600B 395B 4.1B 3.58B 3.31B 3.04B 5.76B 5.86B 39.53B 15.53B 193B 15.4B 15.06B 666B
Net income 42.32B 439M 384M 355M 326M 617M 627M 4.23B 1.66B 20.67B 1.65B 1.61B 71.34B 53.04B 550M 481M 445M 408M 773M 786M 5.31B 2.08B 25.9B 2.07B 2.02B 89.43B
Net Debt -32.67B -339M -296M -274M -251M -476M -484M -3.27B -1.28B -15.95B -1.27B -1.25B -55.07B -54.24B -563M -492M -455M -418M -790M -804M -5.43B -2.13B -26.49B -2.11B -2.07B -91.45B
Logo Dr. Reddy's Laboratories Limited
Dr. Reddy’s Laboratories Limited is an India-based pharmaceutical company. Its products and services are spread across its core businesses of active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars and over-the-counter (OTC) pharmaceutical products. It works in the areas of gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Its segments consist of Global Generics; Pharmaceutical Services and Active Ingredients (PSAI), and Others. The Global Generics segment consists of the Company's business of manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics). The Pharmaceutical Services and Active Ingredients segment consists of the Company's business of manufacturing and marketing APIs and intermediates.
Employees
-
Date Price Change
26-07-17 1,205.80 -1.52%
26-07-16 ₹1,224.40 -0.41%
26-07-15 ₹1,229.50 -1.34%
26-07-14 ₹1,246.20 +0.95%
26-07-13 ₹1,234.50 -0.79%
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
40
Last Close Price
1,223.90INR
Average target price
1,336.30INR
Spread / Average Target
+9.18%

Quarterly revenue - Rate of surprise